Clinical trials
Pediatrics clinical trials
Below are recruiting pediatrics clinical trials, each written for real people, not researchers. We’re tracking 1,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06449001RecruitingPhase 3
Danicopan plus standard therapy for pediatric PNH
This trial tests adding danicopan to a standard treatment (ravulizumab or eculizumab) for children with PNH who still have anemia from extravascular hemolysis. The goal is to see if the combination helps improve red blood cell counts.
Saskatoon, SaskatchewanAges 12–17 - NCT06456892RecruitingPhase 1/Phase 2
Immunotherapy plus chemo for children with hard-to-treat rhabdomyosarcoma
This trial tests if adding the immunotherapy drug Pucotenlimab to standard chemotherapy is safe and effective for children and teens with a type of muscle cancer (rhabdomyosarcoma) that is hard to treat. It may offer a new option for patients whose tumors are difficult to remove with surgery alone.
Guangzhou, GuangdongAges 1–18 - NCT06462430Recruiting
Registry for children with PTEN Hamartoma Tumor Syndrome
This study is creating a registry (a database) of children with PTEN Hamartoma Tumor Syndrome, a condition that can cause growths, large head size, and other health issues. By joining, you help doctors learn more about the condition and how to better care for kids like yours.
IstanbulAges 1 year+ - NCT06464016Recruiting
Infections in Kids With Berlin Heart Pumps
This study looks at infections in children who used a Berlin Heart mechanical heart pump. It aims to find better ways to prevent and treat these infections.
LyonAges 1 day–18 years - NCT06464146RecruitingPhase 3
Comparing nose and mouth pain medicines for broken bones in kids
This study compares three different fast-acting pain medicines given through the nose or by mouth to children with a suspected broken arm or leg in the emergency room. The goal is to find which medicine works best for pain relief within the first hour.
Boulogne-BillancourtAges 2–17 - NCT06464588RecruitingPhase 1
Testing safety of newborn stem cells for dilated cardiomyopathy in young adults and children
This study tests whether a single intravenous infusion of stem cells from donated newborn tissue is safe for people aged 4 to 39 with dilated cardiomyopathy (a weakened, enlarged heart). It aims to find a new option for those who haven't improved enough with standard heart failure medications.
Atlanta, GeorgiaAges 4–40 - NCT06464757Recruiting
Laryngomalacia and breathing in children: before and after treatment study
This trial is for children with laryngomalacia (a floppy voice box) who have noisy breathing and trouble breathing. It will check how they are doing before and after treatment, and follow up for one year to see how their quality of life improves.
OsloAges 1 week–12 months - NCT06465121Recruiting
Ultrasound-guided IV placement for children with difficult veins
This trial tests whether using ultrasound to guide IV placement helps children who are known to have hard-to-find veins. It aims to make the process quicker and less painful.
ReimsAges 1 month–18 years - NCT06477146RecruitingPhase 2
Milk thistle for fatty liver in children and young adults
This trial tests whether milk thistle can help children and young adults with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver unrelated to alcohol use. It aims to see if the supplement can lower liver enzymes and improve liver health.
Cleveland, OhioAges 9–22 - NCT06479278Recruiting
Talk With Me Baby for early language development
This study tests a program called Talk With Me Baby, which coaches parents on talking with their infants to help boost their early language skills during regular well-child checkups. It is for caregivers who speak English and have a healthy full-term baby up to 9 months old.
Kansas City, KansasAges birth–9 months - NCT06485947RecruitingPhase 1
Study testing dinutuximab beta with chemotherapy for neuroblastoma
This trial combines the immunotherapy drug dinutuximab beta with two different chemotherapy regimens to see if it works better for children with high-risk neuroblastoma that has spread. It may be an option for newly diagnosed patients who have not had cancer treatment before.
Utrecht, UtrechtAges 1.5 years–18 years - NCT07692256RecruitingPhase 2
Empagliflozin for heart failure in children
This trial tests if empagliflozin, a diabetes medicine that also helps the heart, can improve symptoms in children with heart failure. It may help kids with severe symptoms or high levels of a heart stress marker called BNP.
Cairo, Cairo GovernorateAges 1 month–18 years - NCT05156398RecruitingPhase 3
Rimegepant to prevent migraine attacks in children
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
Fort Smith, ArkansasAges 6–17 - NCT06572345Recruiting
Low energy diet for teens with obesity and type 2 diabetes
This trial tests whether a low-energy diet using meal replacements can help teenagers with type 2 diabetes improve their blood sugar control. It involves a period of following the diet, then weight management, and includes follow-up visits.
NottinghamAges 12–17 - NCT06486688Recruiting
Virtual program to help teens with substance use risk
This trial tests a virtual program integrated into pediatric check-ups to help teens at risk for alcohol or drug problems. It aims to identify teens who may need extra support and connect them with helpful resources.
Pleasanton, CaliforniaAges 12–17 - NCT06497153Recruiting
Lung ultrasound for children with sickle cell disease
This study tests whether using lung ultrasound can help doctors quickly spot and treat acute chest syndrome in children with sickle cell disease. It may lead to faster, safer care for kids in the intensive care unit.
ParisAges 1 month–17 years - NCT06508775Recruiting
Long-term checkup for Miltenyi cell therapy patients
This study is a long-term check-in for people who received a special type of immunotherapy (CAR T cells) made by Miltenyi. It helps researchers see how you're doing over time after your treatment.
BerlinAges Any age - NCT06508931RecruitingPhase 2
Zamtocabtagene autoleucel for children with B-cell lymphoma or leukemia
This trial tests a new CAR T-cell therapy (zamtocabtagene autoleucel) for children and teens whose B-cell lymphoma or leukemia has come back or hasn't responded to other treatments. The goal is to see if this one-time infusion can help their immune system fight the cancer.
Paris, Boulevard Sérurier 48Ages 6 months–17 years - NCT06514079Recruiting
Steroid injection for stubborn esophageal strictures in children
This trial tests whether adding a steroid injection to esophageal dilation helps children with narrowings that keep coming back. If you have a child with a stubborn narrowing that has already needed dilation, this treatment might help keep it open longer.
Cairo, SelectAges 2–14 - NCT06517810Recruiting
QUELIMMUNE pediatric surveillance registry
This registry tracks children treated with QUELIMMUNE therapy to see how well it works over time. It helps doctors learn more about the treatment's safety and effects in kids.
Birmingham, AlabamaAges Up to 22 years - NCT06520410RecruitingPhase 4
Short vitrectomy tool for children's eye surgery
This trial tests a shorter, 18-millimeter tool for vitrectomy surgery in children. It aims to see if this smaller tool is safe and works well for treating various eye problems in kids.
TaoyuanAges birth–18 years - NCT06529575Recruiting
How skin color affects pulse oximeter accuracy in children
This study checks if a child's skin color affects how well a pulse oximeter (a small clip on the finger that measures oxygen in the blood) works. It involves children having a heart catheterization, where doctors can directly measure oxygen levels, to see if the pulse oximeter gives the same reading.
New York, New YorkAges 4 weeks–18 years - NCT06535087Recruiting
How airway allergies affect children and parents' quality of life
This study looks at how airway allergies (like asthma and hay fever) affect the daily life of children and their parents. By filling out a questionnaire, you can help researchers understand these challenges and find better ways to support families.
Shanghai, Shanghai MunicipalityAges 5–16 - NCT06545890RecruitingPhase 1/Phase 2
Ketofol vs. dexmedetomidine for preventing confusion after waking in kids having eye muscle surgery
This study compares two medicines (Ketofol and dexmedetomidine) to see which better prevents confusion and agitation when children wake up from squint eye surgery. The goal is to find a safer, more comfortable recovery for your child.
CairoAges 2–6
Hear when a new Pediatrics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pediatrics?
- Yes. Clin2 currently lists 1,382 recruiting pediatrics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pediatrics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pediatrics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.